Table 3.
Characteristics of patient population and patient visits, January 1, 2010–July 31, 2011
| Frequency (n [%]) or average (mean [SD]) |
|||||
|---|---|---|---|---|---|
| Bridge House Wednesday Clinic | Ozanam Inn Weekend Clinic | Fleur de Vie at Covenant House | Fleur de Vie in New Orleans East | Total | |
| No. clinic dates | 75 | 35 | 28 | 17 | 155 |
| No. visits | 915 | 248 | 224 | 68 | 1455 |
| No. patients | 362 | 211 | 219 | 67 | 859 |
| No. visits per patient | 3.0 (2.8) | 1.2 (0.5) | 1.0 (0.2) | 1.0 (0.1) | 2.3 (2.4) |
| No. patients per clinic date | 11.0 (3.7) | 7.1 (2.9) | 8.0 (1.9) | 4.0 (2.3) | 8.9 (3.9) |
| Age, y | 37.9 (11.4) | 45.9 (11.2) | 41.3 (13.4) | 37.7 (12.7) | 40.7 (12.4) |
| Male sex | 362 (100) | 203 (96.2) | 101 (46.1) | 32 (48.5) | 698 (81.4) |
| Race/ethnicity | |||||
| African American | — | 108 (54.0) | 88 (54.3) | 21 (34.4) | 217 (51.3) |
| White | — | 84 (42.0) | 32 (19.8) | 0 (0) | 116 (27.4) |
| Hispanic/Latino | — | 3 (1.5) | 40 (24.7) | 21 (34.4) | 64 (15.1) |
| Asian | — | 1 (0.5) | 2 (1.2) | 19 (31.2) | 22 (5.2) |
| Other | — | 4 (2.0) | 0 (0) | 0 (0) | 4 (0.9) |
| Reason for seeking care (chief complaint) | |||||
| Musculoskeletal pain | 89 (9.7) | 47 (19.0) | 33 (14.7) | 5 (7.4) | 174 (12.0) |
| Upper respiratory symptoms | 51 (5.6) | 47 (19.0) | 26 (11.6) | 5 (7.4) | 129 (8.9) |
| Blood pressure check | 56 (6.1) | 23 (9.3) | 16 (7.1) | 3 (4.4) | 98 (6.7) |
| Skin problems | 68 (7.4) | 22 (8.9) | 27 (12.1) | 9 (13.2) | 126 (8.7) |
| Foot problems | 1 (0.1) | 14 (5.7) | 5 (2.2) | 1 (1.5) | 21 (1.4) |
| Oral health issues | 15 (1.6) | 13 (5.3) | 4 (1.8) | 0 (0) | 32 (2.2) |
| Vaccine | 4 (0.4) | 12 (4.9) | 0 (0) | 0 (0) | 16 (1.1) |
| Medication refill | 281 (30.7) | 11 (4.5) | 20 (8.9) | 2 (2.9) | 314 (21.6) |
| Abdominal pain | 0 (0) | 10 (4.0) | 13 (5.8) | 6 (8.8) | 19 (1.3) |
| Tuberculosis test/treatment | 0 (0) | 8 (3.2) | 0 (0) | 0 (0) | 8 (0.6) |
| Glucose check | 0 (0) | 6 (2.4) | 11 (4.9) | 3 (4.4) | 20 (1.4) |
| Gastrointestinal symptoms | 25 (2.7) | 5 (2.0) | 0 (0) | 0 (0) | 30 (2.1) |
| Intake physical | 159 (17.2) | 0 (0) | 0 (0) | 0 (0) | 159 (10.9) |
| Neuropathic pain | 12 (1.3) | 0 (0) | 0 (0) | 0 (0) | 12 (0.8) |
| Psychiatric issues | 55 (6.0) | 4 (1.6) | 0 (0) | 0 (0) | 59 (4.1) |
| Sleep issues | 51 (5.6) | 1 (0.4) | 0 (0) | 0 (0) | 52 (3.6) |
| Gynecological issues | 0 (0) | 0 (0) | 16 (7.1) | 5 (7.4) | 21 (1.4) |
| Urological issues | 0 (0) | 0 (0) | 0 (0) | 2 (2.9) | 2 (0.1) |
| Other | 50 (5.5) | 24 (9.7) | 41 (18.3) | 27 (39.7) | 142 (9.2) |
| Counseling and health education topics | |||||
| Smoking cessation | 49 (5.4) | 27 (10.9) | 44 (19.6) | 11 (16.2) | 131 (9.0) |
| Upper respiratory symptom management | 9 (1.0) | 20 (8.1) | 3 (1.3) | 2 (2.9) | 34 (2.3) |
| Hypertension management | 24 (2.6) | 11 (4.4) | 33 (14.7) | 16 (23.5) | 84 (5.8) |
| Diabetes management | 2 (0.2) | 5 (2.0) | 76 (33.9) | 20 (29.4) | 103 (7.1) |
| Other | 1 (0.1) | 6 (2.4) | 13 (5.8) | 7 (10.3) | 27 (1.9) |
| Referrals | |||||
| Primary care | 35 (3.8) | 73 (29.4) | 124 (55.4) | 36 (52.9) | 268 (18.4) |
| Dental care | 20 (2.2) | 22 (8.9) | 7 (3.1) | 1 (1.5) | 50 (3.4) |
| Psychiatric treatment | 38 (4.2) | 20 (8.1) | 12 (5.4) | 1 (1.5) | 71 (4.9) |
| Emergency department | 2 (0.2) | 16 (6.5) | 3 (1.3) | 0 (0) | 21 (1.4) |
| Substance abuse treatment | 0 (0) | 9 (3.6) | 4 (1.8) | 0 (0) | 13 (0.9) |
| Social work | 0 (0) | 8 (3.2) | 0 (0) | 0 (0) | 13 (0.9) |
| Orthopedics | 7 (0.8) | 5 (2.0) | 1 (0.4) | 0 (0) | 13 (0.9) |
| HIV testing/treatment | 6 (0.7) | 5 (2.0) | 0 (0) | 0 (0) | 11 (0.8) |
| Gastroenterology clinic | 0 (0) | 5 (2.0) | 0 (0) | 2 (2.9) | 7 (0.5) |
| Hepatitis C clinic | 5 (0.5) | 5 (2.0) | 2 (0.8) | 0 (0) | 12 (0.8) |
| Tuberculosis clinic | 0 (0) | 4 (1.6) | 0 (0) | 0 (0) | 4 (0.3) |
| Sexually transmitted disease clinic | 1 (0.1) | 4 (1.6) | 0 (0) | 0 (0) | 5 (0.3) |
| Other | 28 (3.1) | 14 (5.6) | 36 (16.1) | 10 (14.7) | 88 (6.0) |
| Prescriptions | |||||
| Nonsteroidal anti-inflammatory drugs/aspirin | 198 (21.6) | 57 (23.0) | 46 (20.5) | 10 (14.7) | 311 (21.4) |
| Antibacterial or antifungal medication | 54 (5.9) | 37 (14.9) | 49 (21.9) | 15 (22.1) | 155 (10.7) |
| Antihypertensive medication | 147 (16.1) | 24 (9.7) | 47 (21.0) | 6 (8.8) | 224 (15.4) |
| Lipid-lowering medication | 7 (0.8) | 4 (1.6) | 4 (1.8) | 1 (1.5) | 16 (1.1) |
| Gastroesophageal reflux disease medication | 56 (6.1) | 5 (2.0) | 5 (2.2) | 1 (1.5) | 67 (4.6) |
| Psychiatric medication | 139 (15.2) | 12 (4.8) | 12 (5.4) | 0 (0) | 163 (11.2) |
| Sleep medication | 173 (18.9) | 0 (0) | 0 (0) | 0 (0) | 173 (11.9) |
| Allergy medication | 51 (5.6) | 6 (2.4) | 6 (2.7) | 0 (0) | 63 (4.3) |
| Asthma medication | 10 (1.1) | 7 (2.8) | 7 (3.1) | 2 (2.9) | 26 (1.8) |
| Cold and cough medication | 16 (1.8) | 14 (5.6) | 0 (0) | 0 (0) | 30 (2.1) |
| Topical skin treatment | 18 (2.0) | 7 (2.8) | 4 (1.8) | 2 (2.9) | 31 (2.1) |
| Smoking cessation | 15 (1.6) | 2 (0.8) | 0 (0) | 0 (0) | 17 (1.2) |
| Other | 178 (19.5) | 21 (8.5) | 47 (21.0) | 11 (16.2) | 257 (17.7) |
| Hepatitis A and B vaccines | 0 (0) | 18 (7.3) | 0 (0) | 0 (0) | 18 (1.2) |
| Influenza vaccine | 6 (0.7) | 17 (6.9) | 1 (0.5) | 1 (1.5) | 25 (1.8) |
| Tuberculosis test | 325 (35.5) | 10 (4.0) | 0 (0) | 0 (0) | 335 (23.0) |
HIV, human immunodeficiency virus; SD, standard deviation.